CTRI/2009/091/001078招募中3 期
Randomised , triple blinded, placebo controlled, clinical trial to compare the effect of Ketorolac tromethamine 0.4% in prophylactically preventing Cystoid Macula Edema following Cataract Surgery
I0 个研究点目标入组 704 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 704
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Adult males and females 50-70 years of age coming for cataract surgery to our hospital.
- •Staying within 40 kms of Vellore town.
排除标准
- •Inabiltity to visualise the macula preoperatively in the eye to be operated.
- •Ocular disease that can affect macular function.
- •Uncontrolled Diabetics defined by RBS/PP Sugars > 200mg/dl.
- •Diabetic Maculopathy with Edema in eye to be operated.
- •Past History of intraocular surgery in the eye under consideration.
- •History of use of Topical steroid drops or NSAID drops within the past 30 days prior to enrolment.
- •Current use of Oral steroids.
- •Known NSAIDs Allergy.
研究者
相似试验
进行中（未招募）
不适用
Randomised, double blinded, placebo controlled, parallel group study toevaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients withallergic rhinitis and/or rhinoconjunctivitis with or without mild intermittentasthma.EUCTR2008-002264-34-LTETI Pharma GmbH210
进行中（未招募）
1 期
Randomised, double blinded, placebo controlled, parallel group study to evaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients with allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma.EUCTR2008-002264-34-PLETI Pharma GmbH210
进行中（未招募）
不适用
Randomised, double blinded, placebo controlled, parallel group study toevaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients withallergic rhinitis and/or rhinoconjunctivitis with or without mild intermittentasthma.EUCTR2008-002264-34-DEETI Pharma GmbH210
进行中（未招募）
不适用
Randomised, double blinded, placebo controlled, parallel group study toevaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients withallergic rhinitis and/or rhinoconjunctivitis with or without mild intermittentasthma.Allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma caused by clinical relevant sensitisation against grass pollen AND birch pollen.MedDRA version: 9.1Level: LLTClassification code 10039097Term: RhinoconjunctivitisMedDRA version: 9.1Level: LLTClassification code 10039095Term: Rhinitis seasonalEUCTR2008-002264-34-BGETI Pharma GmbH210
已完成
不适用
Clinical Study to Evaluate the Efficacy, Dose-response and Safety of SA09012 in Bronchial Asthma PatientsDiseases of th respiratory systemKCT0000571Sama Pharm234